[1] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[2] |
BAI Zhaofang, ZHAN Xiaoyan, YAO Qing, CHEN Simin, ZHAO Xu, XIAO Xiaohe.
Theoretical innovation and technological breakthroughs in the safety evaluation of traditional Chinese medicine: disease-syndrome-based toxicology
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 6-14.
|
[3] |
GAO Yuan, SHI Wei, XIAO Xiaohe, BAI Zhaofang, WANG Jiabo.
Research progress on the animal models of idiosyncratic drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 33-39.
|
[4] |
ZHANG Jingsheng, JI Zuen, PANG Bo, XU Yingli, CAO Shan, ZHANG Yu, SUN Qiyue, SUN Jing, LI Shuran, ZHANG Wei, ZHAO Ronghua, CUI Xiaolan.
Discussion on traditional Chinese medicine theory and modern pharmacology of Xuanfei Baidu decoction for treating novel coronavirus infection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 55-58.
|
[5] |
YANG Zhenzhen, CHANG Cheng, GAO Na, ZHANG Xiaolin, SONG Yinsen, LIU Ying, FAN Tianli.
Molecular mechanism of luteolin for inhibiting esophageal squamous cell carcinoma based on network pharmacology and in vitro studies
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 992-1001.
|
[6] |
YIN Yuling, HU Chujuan, ZHANG Xiaomeng, WANG Yu, ZHANG Bing, LIN Zhijian.
Mining and validation of anti-adriamycin cardiotoxic effect of chicory extract
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 858-865.
|
[7] |
MEI Yu, ZHU Yue, ZHANG Huiting, XIAO Chengrong, GAO Yue, MA Zengchun.
Protective mechanism of Chinese medicine compound CB001 against low dose radiation based on network pharmacology and experimental verification
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 872-879.
|
[8] |
DILHUMAR Dilmurat, SHI Wei, WANG Jiabo, GAO Yuan.
Research progress in safe use of Psoralea corylifolia based on evolution of toxicity/efficacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 939-945.
|
[9] |
WANG Rong, LIU Ziqun, WANG Nana, TAN Xiong, ZHANG Yixin, YANG Kuan, QIN Bei.
Acute toxicity of proline Danshensu borneol ester in mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 754-757.
|
[10] |
SU Yuefen, ZHENG Jingrou, GONG He, XIE Guangtong, ZHANG Jie, SAI Chunmei.
Formability and mechanism of breast nodule pain-alleviating gel plaster for the treatment of breast hyperplasia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 783-790.
|
[11] |
SHEN Pan, SUN Dezhi, ZHOU Wei, GAO Yue.
Research progress in toxicity prediction of traditional Chinese medicines
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 473-479.
|
[12] |
CHEN Mengping, WANG Yaxin, YAO Rongmei, BAO Lei, ZHAO Ronghua, SUN Jing, GENG Zihan, BAO Yanyan, DAI Min, GUO Shanshan, CUI Xiaolan.
Mechanisms of Qingkailing soft capsules against coronavirus pneumonia based on network pharmacology and experimental verification
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 253-257.
|
[13] |
FU Changli, LU Yuan, CHEN Siying, WANG Yonglin, LI Yongjun, WANG Aimin, LIU Chunhua.
Mechanisms of Laportea bulbifera against rheumatoid arthritis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 171-176.
|
[14] |
WANG Xiaohui, ZHANG Fan, XIA Wenbin, WEI Yuhui.
Mechanisms of genipin-induced hepatotoxicity by using network pharmacology and transcriptomics
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 177-180.
|
[15] |
CAO Lin, RAN Zheng, HOU Qiang, QIU Zuocheng, YANG Jianhua.
Chemical composition of Huatie compound and prediction of potential mechanism for prevention and treatment of hyperplasia of mammary glands
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1113-1120.
|